세계의 리가제 효소 시장 : 시장 규모 및 점유율 분석 - 동향, 촉진요인, 경쟁 구도, 예측(2025-2032년)

Ligases Enzyme Market Size & Share Analysis - Trends, Drivers, Competitive Landscape, and Forecasts (2025 - 2032)

US $ 4,900 ￦ 7,012,000

Unprintable PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄는 불가능합니다.

US $ 6,400 ￦ 9,159,000

Printable PDF (Group User License)

PDF 보고서를 동일 사업장에서 5명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,400 ￦ 12,022,000

Printable PDF (Enterprise License)

PDF 보고서를 동일 기업 및 자회사의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

세계 리가제 효소 시장 규모는 6.6%의 연평균 복합 성장률(CAGR)로 확대되어 2024년 4억 4,210만 달러에서 2032년 7억 2,740만 달러로 성장할 것으로 예상됩니다. 이러한 성장의 원동력은 유전자 이상 및 감염성 질환 진단의 중요성 증가와 전 세계 암 발병률 증가에 기인합니다. 리가제 효소는 정밀의료 및 맞춤치료 접근법이 빠르게 발전하고 있는 분자진단, 유전자 편집, 바이오의약품 생산 등 다양한 분야에서 필수적인 역할을 하고 있습니다.

T4 DNA 리가제는 클로닝 및 염기서열 분석에서 DNA 조각의 빠른 결합을 가능하게 하여 분자 클로닝 및 유전공학 응용의 효율을 높이며, T4 DNA 리가제는 클로닝 및 염기서열 분석에서 DNA 조각의 결합에 널리 사용되며, 대장균 DNA 리가제는 DNA 복구 및 복제 연구에 필수적입니다. Tth DNA 리가제는 특정 DNA 서열을 검출하기 위한 리가제 연쇄반응 기술에 사용되며, T4 RNA 리가제는 RNA 연구에서 단일가닥 RNA의 결찰에 사용되며, Pfu DNA 리가제는 유전자 분석을 위한 고충실도 DNA 증폭 및 클로닝에 적용되고 있습니다. 적용되고 있습니다.

고세균에서 추출한 효소는 열악한 조건에서도 안정적인 것으로 알려져 있어 산업적 응용에 유리합니다. 대장균은 생산이 용이하고 연구 및 진단에 널리 적용될 수 있기 때문에 리가제의 일반적인 공급원이며, Thermus thermophilus는 고온 응용 분야에 내열성 리가제를 제공하고, Pyrococcus furiosus는 극한 온도 공정에 내열성이 높은 리가제를 제공합니다. 제공합니다.

리가제는 분자 클로닝에서 재조합 DNA 분자의 구축에 필수적이며, 유전자 연구와 생명공학 개발을 촉진합니다. 리가제는 고처리량 유전체 연구를 위한 차세대 시퀀싱과 진단의 민감도 향상을 위한 리가제 연쇄반응 기술에서 중요한 역할을 하고 있습니다. 리가제는 또한 유전자 변이 식별, 롤링 서클 증폭에서 고리형 DNA 증폭, 근접 결합 분석에서 단백질 상호 작용을 감지하는 데에도 도움이 됩니다. 유전체 매핑을 위한 라이게이션 매개 PCR에서 DNA 서열의 증폭을 촉진합니다.

제약회사 및 바이오 제약회사는 의약품 개발, 유전자 연구 및 생명공학 응용을 위한 리가제의 주요 수요처입니다. 연구기관은 다양한 분자생물학적 실험에 리가제를 활용하고, 진단연구소는 유전자 질환 및 감염성 질환을 검출하기 위한 분석에 리가제를 활용합니다.

북미가 가장 큰 시장 점유율을 차지하고 있는 이유는 높은 수준의 의료 인프라, 막대한 R&D 투자, 높은 유전성 질환 및 암 유병률에 기인합니다. 아시아태평양은 의료비 지출 증가, 유전 질환에 대한 인식 증가, 생명공학 연구 활동의 확대로 인해 급성장할 것으로 예상됩니다.

암과 유전성 질환의 유병률 증가는 진단 및 치료 분야에서 리가제 수요를 주도하고 있습니다. 리가제는 DNA 복구 및 복제 과정에서 매우 중요한 역할을 하기 때문입니다. 분자진단의 발전과 바이오 제약 산업의 성장은 생물학적 제제 및 유전자 치료제 개발에서 리가제의 필요성을 증가시키고 있습니다.

이 보고서는 세계의 리가제 효소 시장을 조사했으며, 시장 개요와 함께 제품별/유래별/용도별/최종사용자별/지역별 동향, 시장 진출기업 프로파일 등의 정보를 제공합니다.

목차

제1장 조사 범위

제2장 조사 방법

제3장 주요 요약

제4장 시장 지표

제5장 업계 전망

• 업계 배경
• 시장 역학
• COVID-19의 영향
• 사회 정치적 영향
• Porter의 Five Forces 분석
• 혁신 및 기술 동향
• 경제와 규제에 대한 영향
• 시장 진출 전략

제6장 경쟁 구도

• 시장 진출기업과 제공 제품 리스트
• 주요 시장 진출기업의 경쟁 벤치마킹
• 주요 시장 진출기업의 제품 벤치마킹
• 주요 시장 진출기업의 최근 전략적 전개
• 기업 리더십 매트릭스

제7장 세계 시장

• 개요
• 시장 매출, 제품별(2019년-2032년)
• 시장 매출, 유래별(2019년-2032년)
• 시장 매출, 용도별(2019년-2032년)
• 시장 매출, 최종사용자별(2019년-2032년)
• 시장 매출, 지역별(2019년-2032년)

제8장 북미 시장

제9장 유럽 시장

제10장 아시아태평양 시장

제11장 라틴아메리카 시장

제12장 중동 및 아프리카 시장

제13장 미국 시장

제14장 캐나다 시장

제15장 독일 시장

제16장 영국 시장

제17장 프랑스 시장

제18장 이탈리아 시장

제19장 스페인 시장

제20장 일본 시장

제21장 중국 시장

제22장 인도 시장

제23장 한국 시장

제24장 호주 시장

제25장 브라질 시장

제26장 멕시코 시장

제27장 사우디아라비아 시장

제28장 남아프리카공화국 시장

제29장 아랍에미리트(UAE) 시장

제30장 기업 개요

제31장 부록

LSH

영문 목차

영문목차

The global ligases enzyme market is projected to grow from $442.1 million in 2024 to $727.4 million by 2032, reflecting a compound annual growth rate (CAGR) of 6.6%. This growth is driven by the increasing importance of diagnosing genetic abnormalities and infectious diseases, as well as the rising prevalence of cancer worldwide. Ligases enzymes are essential in various applications, including molecular diagnostics, gene editing, and biopharmaceutical production, where precision medicine and personalized treatment approaches are rapidly advancing.

Key Insights

Quick ligase enhances efficiency in molecular cloning and genetic engineering applications by enabling rapid ligation of DNA fragments. T4 DNA ligase is widely used for joining DNA fragments in cloning and sequencing, while E. coli DNA ligase is crucial for DNA repair and replication studies. Tth DNA ligase is employed in ligase chain reaction techniques for detecting specific DNA sequences. T4 RNA ligase is used in RNA research for ligating single-stranded RNA, and Pfu DNA ligase is applied in high-fidelity DNA amplification and cloning for genetic analyses.

Enzymes derived from archaebacterium are known for their stability under extreme conditions, making them beneficial in industrial applications. Escherichia coli is a common source for ligases due to ease of production and wide applicability in research and diagnostics. Thermus thermophilus provides thermostable ligases for high-temperature applications, while Pyrococcus furiosus offers highly thermostable ligases for extreme temperature processes.

Ligases are essential for constructing recombinant DNA molecules in molecular cloning, facilitating genetic research and biotechnology developments. They play a role in next-generation sequencing for high-throughput genomics studies and in ligase chain reaction techniques for enhanced sensitivity in diagnostics. Ligases also assist in identifying genetic mutations, amplifying circular DNA in rolling circle amplification, and detecting protein interactions in proximity ligation assays. They facilitate amplification of DNA sequences in ligation-mediated PCR for genomic mapping.

Pharmaceutical and biopharmaceutical companies are major consumers of ligases for drug development, genetic research, and biotechnological applications. Research laboratories utilize ligases in various molecular biology experiments, while diagnostic laboratories employ them in assays for detecting genetic disorders and infectious diseases.

North America holds the largest market share due to advanced healthcare infrastructure, significant R&D investments, and a high prevalence of genetic disorders and cancer. Asia-Pacific is expected to experience the fastest growth, driven by increasing healthcare expenditures, rising awareness of genetic diseases, and expanding biotechnological research activities.

Rising prevalence of cancer and genetic disorders drives the demand for ligases in diagnostic and therapeutic applications, as these enzymes are crucial in DNA repair and replication processes. Advancements in molecular diagnostics and the growth of the biopharmaceutical industry amplify the need for ligases in biologics and gene therapy development.

Ligases are vital components in gene editing technologies like CRISPR, enabling precise genetic modifications for therapeutic purposes. Innovations in high-fidelity ligases with improved accuracy and efficiency further enhance their applicability in research and clinical settings.

The market is fragmented, with key players focusing on product innovation, strategic partnerships, and mergers and acquisitions to strengthen their position.

Table of Contents

Chapter 1. Research Scope

• 1.1. Research Objectives
• 1.2. Market Definition
• 1.3. Analysis Period
• 1.4. Market Size Breakdown by Segments
  • 1.4.1. Market Size Breakdown, by Product
  • 1.4.2. Market Size Breakdown, by Source
  • 1.4.3. Market Size Breakdown, by Application
  • 1.4.4. Market Size Breakdown, by End User
  • 1.4.5. Market Size Breakdown, by Region
  • 1.4.6. Market Size Breakdown, by Country
• 1.5. Market Data Reporting Unit
  • 1.5.1. Revenue
• 1.6. Key Stakeholders

Chapter 2. Research Methodology

• 2.1. Secondary Research
  • 2.1.1. Paid
  • 2.1.2. Unpaid
  • 2.1.3. P&S Intelligence Database
• 2.2. Primary Research
• 2.3. Market Size Estimation
• 2.4. Data Triangulation
• 2.5. Currency Conversion Rates
• 2.6. Assumptions for the Study
• 2.7. Notes and Caveats

Chapter 3. Executive Summary

Chapter 4. Market Indicators

Chapter 5. Industry Outlook

• 5.1. Industry Background
• 5.2. Market Dynamics
  • 5.2.1. Trends
  • 5.2.2. Drivers
  • 5.2.3. Restraints/Challenges
  • 5.2.4. Emerging Economies and Key Opportunities
  • 5.2.5. Impact Analysis of Drivers/Restraints
• 5.3. Impact of COVID-19
• 5.4. Sociopolitical Impact
• 5.5. Porter's Five Forces Analysis
  • 5.5.1. Bargaining Power of Buyers
  • 5.5.2. Bargaining Power of Suppliers
  • 5.5.3. Threat of New Entrants
  • 5.5.4. Intensity of Rivalry
  • 5.5.5. Threat of Substitutes
• 5.6. Innovation and Technology Trends
• 5.7. Economic and Regulatory Impact
• 5.8. Market Entry Strategies

Chapter 6. Competitive Landscape

• 6.1. List of Market Players and their Offerings
• 6.2. Competitive Benchmarking of Key Players
• 6.3. Product Benchmarking of Key Players
• 6.4. Recent Strategic Developments by Key Players
• 6.5. Company Leadership Matrix

Chapter 7. Global Market

• 7.1. Overview
• 7.2. Market Revenue, by Product (2019-2032)
• 7.3. Market Revenue, by Source (2019-2032)
• 7.4. Market Revenue, by Application (2019-2032)
• 7.5. Market Revenue, by End User (2019-2032)
• 7.6. Market Revenue, by Region (2019-2032)

Chapter 8. North America Market

• 8.1. Overview
• 8.2. Market Revenue, by Product (2019-2032)
• 8.3. Market Revenue, by Source (2019-2032)
• 8.4. Market Revenue, by Application (2019-2032)
• 8.5. Market Revenue, by End User (2019-2032)
• 8.6. Market Revenue, by Country (2019-2032)

Chapter 9. Europe Market

• 9.1. Overview
• 9.2. Market Revenue, by Product (2019-2032)
• 9.3. Market Revenue, by Source (2019-2032)
• 9.4. Market Revenue, by Application (2019-2032)
• 9.5. Market Revenue, by End User (2019-2032)
• 9.6. Market Revenue, by Country (2019-2032)

Chapter 10. Asia-Pacific Market

• 10.1. Overview
• 10.2. Market Revenue, by Product (2019-2032)
• 10.3. Market Revenue, by Source (2019-2032)
• 10.4. Market Revenue, by Application (2019-2032)
• 10.5. Market Revenue, by End User (2019-2032)
• 10.6. Market Revenue, by Country (2019-2032)

Chapter 11. Latin America Market

• 11.1. Overview
• 11.2. Market Revenue, by Product (2019-2032)
• 11.3. Market Revenue, by Source (2019-2032)
• 11.4. Market Revenue, by Application (2019-2032)
• 11.5. Market Revenue, by End User (2019-2032)
• 11.6. Market Revenue, by Country (2019-2032)

Chapter 12. Middle East and Africa Market

• 12.1. Overview
• 12.2. Market Revenue, by Product (2019-2032)
• 12.3. Market Revenue, by Source (2019-2032)
• 12.4. Market Revenue, by Application (2019-2032)
• 12.5. Market Revenue, by End User (2019-2032)
• 12.6. Market Revenue, by Country (2019-2032)

Chapter 13. U.S. Market

• 13.1. Overview
• 13.2. Economic Indicators
• 13.3. Demographics and Population Insights
• 13.4. Regional Hotspots
• 13.5. Growth Drivers
• 13.6. Challenges and Barriers
• 13.7. Competitive Strategies
• 13.8. Emerging Players
• 13.9. Compliance Requirements
• 13.10. Emerging Investment Areas
• 13.11. Market Size and Forecast
  • 13.11.1. Market Revenue, by Product (2019-2032)
  • 13.11.2. Market Revenue, by Source (2019-2032)
  • 13.11.3. Market Revenue, by Application (2019-2032)
  • 13.11.4. Market Revenue, by End User (2019-2032)

Chapter 14. Canada Market

• 14.1. Overview
• 14.2. Economic Indicators
• 14.3. Demographics and Population Insights
• 14.4. Regional Hotspots
• 14.5. Growth Drivers
• 14.6. Challenges and Barriers
• 14.7. Competitive Strategies
• 14.8. Emerging Players
• 14.9. Compliance Requirements
• 14.10. Emerging Investment Areas
• 14.11. Market Size and Forecast
  • 14.11.1. Market Revenue, by Product (2019-2032)
  • 14.11.2. Market Revenue, by Source (2019-2032)
  • 14.11.3. Market Revenue, by Application (2019-2032)
  • 14.11.4. Market Revenue, by End User (2019-2032)

Chapter 15. Germany Market

• 15.1. Overview
• 15.2. Economic Indicators
• 15.3. Demographics and Population Insights
• 15.4. Regional Hotspots
• 15.5. Growth Drivers
• 15.6. Challenges and Barriers
• 15.7. Competitive Strategies
• 15.8. Emerging Players
• 15.9. Compliance Requirements
• 15.10. Emerging Investment Areas
• 15.11. Market Size and Forecast
  • 15.11.1. Market Revenue, by Product (2019-2032)
  • 15.11.2. Market Revenue, by Source (2019-2032)
  • 15.11.3. Market Revenue, by Application (2019-2032)
  • 15.11.4. Market Revenue, by End User (2019-2032)

Chapter 16. U.K. Market

• 16.1. Overview
• 16.2. Economic Indicators
• 16.3. Demographics and Population Insights
• 16.4. Regional Hotspots
• 16.5. Growth Drivers
• 16.6. Challenges and Barriers
• 16.7. Competitive Strategies
• 16.8. Emerging Players
• 16.9. Compliance Requirements
• 16.10. Emerging Investment Areas
• 16.11. Market Size and Forecast
  • 16.11.1. Market Revenue, by Product (2019-2032)
  • 16.11.2. Market Revenue, by Source (2019-2032)
  • 16.11.3. Market Revenue, by Application (2019-2032)
  • 16.11.4. Market Revenue, by End User (2019-2032)

Chapter 17. France Market

• 17.1. Overview
• 17.2. Economic Indicators
• 17.3. Demographics and Population Insights
• 17.4. Regional Hotspots
• 17.5. Growth Drivers
• 17.6. Challenges and Barriers
• 17.7. Competitive Strategies
• 17.8. Emerging Players
• 17.9. Compliance Requirements
• 17.10. Emerging Investment Areas
• 17.11. Market Size and Forecast
  • 17.11.1. Market Revenue, by Product (2019-2032)
  • 17.11.2. Market Revenue, by Source (2019-2032)
  • 17.11.3. Market Revenue, by Application (2019-2032)
  • 17.11.4. Market Revenue, by End User (2019-2032)

Chapter 18. Italy Market

• 18.1. Overview
• 18.2. Economic Indicators
• 18.3. Demographics and Population Insights
• 18.4. Regional Hotspots
• 18.5. Growth Drivers
• 18.6. Challenges and Barriers
• 18.7. Competitive Strategies
• 18.8. Emerging Players
• 18.9. Compliance Requirements
• 18.10. Emerging Investment Areas
• 18.11. Market Size and Forecast
  • 18.11.1. Market Revenue, by Product (2019-2032)
  • 18.11.2. Market Revenue, by Source (2019-2032)
  • 18.11.3. Market Revenue, by Application (2019-2032)
  • 18.11.4. Market Revenue, by End User (2019-2032)

Chapter 19. Spain Market

• 19.1. Overview
• 19.2. Economic Indicators
• 19.3. Demographics and Population Insights
• 19.4. Regional Hotspots
• 19.5. Growth Drivers
• 19.6. Challenges and Barriers
• 19.7. Competitive Strategies
• 19.8. Emerging Players
• 19.9. Compliance Requirements
• 19.10. Emerging Investment Areas
• 19.11. Market Size and Forecast
  • 19.11.1. Market Revenue, by Product (2019-2032)
  • 19.11.2. Market Revenue, by Source (2019-2032)
  • 19.11.3. Market Revenue, by Application (2019-2032)
  • 19.11.4. Market Revenue, by End User (2019-2032)

Chapter 20. Japan Market

• 20.1. Overview
• 20.2. Economic Indicators
• 20.3. Demographics and Population Insights
• 20.4. Regional Hotspots
• 20.5. Growth Drivers
• 20.6. Challenges and Barriers
• 20.7. Competitive Strategies
• 20.8. Emerging Players
• 20.9. Compliance Requirements
• 20.10. Emerging Investment Areas
• 20.11. Market Size and Forecast
  • 20.11.1. Market Revenue, by Product (2019-2032)
  • 20.11.2. Market Revenue, by Source (2019-2032)
  • 20.11.3. Market Revenue, by Application (2019-2032)
  • 20.11.4. Market Revenue, by End User (2019-2032)

Chapter 21. China Market

• 21.1. Overview
• 21.2. Economic Indicators
• 21.3. Demographics and Population Insights
• 21.4. Regional Hotspots
• 21.5. Growth Drivers
• 21.6. Challenges and Barriers
• 21.7. Competitive Strategies
• 21.8. Emerging Players
• 21.9. Compliance Requirements
• 21.10. Emerging Investment Areas
• 21.11. Market Size and Forecast
  • 21.11.1. Market Revenue, by Product (2019-2032)
  • 21.11.2. Market Revenue, by Source (2019-2032)
  • 21.11.3. Market Revenue, by Application (2019-2032)
  • 21.11.4. Market Revenue, by End User (2019-2032)

Chapter 22. India Market

• 22.1. Overview
• 22.2. Economic Indicators
• 22.3. Demographics and Population Insights
• 22.4. Regional Hotspots
• 22.5. Growth Drivers
• 22.6. Challenges and Barriers
• 22.7. Competitive Strategies
• 22.8. Emerging Players
• 22.9. Compliance Requirements
• 22.10. Emerging Investment Areas
• 22.11. Market Size and Forecast
  • 22.11.1. Market Revenue, by Product (2019-2032)
  • 22.11.2. Market Revenue, by Source (2019-2032)
  • 22.11.3. Market Revenue, by Application (2019-2032)
  • 22.11.4. Market Revenue, by End User (2019-2032)

Chapter 23. South Korea Market

• 23.1. Overview
• 23.2. Economic Indicators
• 23.3. Demographics and Population Insights
• 23.4. Regional Hotspots
• 23.5. Growth Drivers
• 23.6. Challenges and Barriers
• 23.7. Competitive Strategies
• 23.8. Emerging Players
• 23.9. Compliance Requirements
• 23.10. Emerging Investment Areas
• 23.11. Market Size and Forecast
  • 23.11.1. Market Revenue, by Product (2019-2032)
  • 23.11.2. Market Revenue, by Source (2019-2032)
  • 23.11.3. Market Revenue, by Application (2019-2032)
  • 23.11.4. Market Revenue, by End User (2019-2032)

Chapter 24. Australia Market

• 24.1. Overview
• 24.2. Economic Indicators
• 24.3. Demographics and Population Insights
• 24.4. Regional Hotspots
• 24.5. Growth Drivers
• 24.6. Challenges and Barriers
• 24.7. Competitive Strategies
• 24.8. Emerging Players
• 24.9. Compliance Requirements
• 24.10. Emerging Investment Areas
• 24.11. Market Size and Forecast
  • 24.11.1. Market Revenue, by Product (2019-2032)
  • 24.11.2. Market Revenue, by Source (2019-2032)
  • 24.11.3. Market Revenue, by Application (2019-2032)
  • 24.11.4. Market Revenue, by End User (2019-2032)

Chapter 25. Brazil Market

• 25.1. Overview
• 25.2. Economic Indicators
• 25.3. Demographics and Population Insights
• 25.4. Regional Hotspots
• 25.5. Growth Drivers
• 25.6. Challenges and Barriers
• 25.7. Competitive Strategies
• 25.8. Emerging Players
• 25.9. Compliance Requirements
• 25.10. Emerging Investment Areas
• 25.11. Market Size and Forecast
  • 25.11.1. Market Revenue, by Product (2019-2032)
  • 25.11.2. Market Revenue, by Source (2019-2032)
  • 25.11.3. Market Revenue, by Application (2019-2032)
  • 25.11.4. Market Revenue, by End User (2019-2032)

Chapter 26. Mexico Market

• 26.1. Overview
• 26.2. Economic Indicators
• 26.3. Demographics and Population Insights
• 26.4. Regional Hotspots
• 26.5. Growth Drivers
• 26.6. Challenges and Barriers
• 26.7. Competitive Strategies
• 26.8. Emerging Players
• 26.9. Compliance Requirements
• 26.10. Emerging Investment Areas
• 26.11. Market Size and Forecast
  • 26.11.1. Market Revenue, by Product (2019-2032)
  • 26.11.2. Market Revenue, by Source (2019-2032)
  • 26.11.3. Market Revenue, by Application (2019-2032)
  • 26.11.4. Market Revenue, by End User (2019-2032)

Chapter 27. Saudi Arabia Market

• 27.1. Overview
• 27.2. Economic Indicators
• 27.3. Demographics and Population Insights
• 27.4. Regional Hotspots
• 27.5. Growth Drivers
• 27.6. Challenges and Barriers
• 27.7. Competitive Strategies
• 27.8. Emerging Players
• 27.9. Compliance Requirements
• 27.10. Emerging Investment Areas
• 27.11. Market Size and Forecast
  • 27.11.1. Market Revenue, by Product (2019-2032)
  • 27.11.2. Market Revenue, by Source (2019-2032)
  • 27.11.3. Market Revenue, by Application (2019-2032)
  • 27.11.4. Market Revenue, by End User (2019-2032)

Chapter 28. South Africa Market

• 28.1. Overview
• 28.2. Economic Indicators
• 28.3. Demographics and Population Insights
• 28.4. Regional Hotspots
• 28.5. Growth Drivers
• 28.6. Challenges and Barriers
• 28.7. Competitive Strategies
• 28.8. Emerging Players
• 28.9. Compliance Requirements
• 28.10. Emerging Investment Areas
• 28.11. Market Size and Forecast
  • 28.11.1. Market Revenue, by Product (2019-2032)
  • 28.11.2. Market Revenue, by Source (2019-2032)
  • 28.11.3. Market Revenue, by Application (2019-2032)
  • 28.11.4. Market Revenue, by End User (2019-2032)

Chapter 29. U.A.E. Market

• 29.1. Overview
• 29.2. Economic Indicators
• 29.3. Demographics and Population Insights
• 29.4. Regional Hotspots
• 29.5. Growth Drivers
• 29.6. Challenges and Barriers
• 29.7. Competitive Strategies
• 29.8. Emerging Players
• 29.9. Compliance Requirements
• 29.10. Emerging Investment Areas
• 29.11. Market Size and Forecast
  • 29.11.1. Market Revenue, by Product (2019-2032)
  • 29.11.2. Market Revenue, by Source (2019-2032)
  • 29.11.3. Market Revenue, by Application (2019-2032)
  • 29.11.4. Market Revenue, by End User (2019-2032)

Chapter 30. Company Profiles

Chapter 31. Appendix

• 31.1. Sources and References
• 31.2. Related Reports

관련자료